| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/17/2004 | CA2143325C Cloning and expression of .beta.app-c100 receptor |
| 02/17/2004 | CA2112667C Monoclonal antibodies to putative hcv ns5 proteins and methods for using same |
| 02/12/2004 | WO2004013334A1 Clubroot resistant brassica oleracea plants |
| 02/12/2004 | WO2004013331A1 Pathogenic genes of xanthomonas oryzae pv. oryzae and utilization thereof |
| 02/12/2004 | WO2004013316A1 Method for isolation of pluripotent stem cells |
| 02/12/2004 | WO2004013315A1 Method for the preparation, purification and differentiation of neurospheres from mammalian stem cells |
| 02/12/2004 | WO2004013309A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 02/12/2004 | WO2004013308A2 Maxs as modifiers of the axin pathway and methods of use |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013280A2 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING |
| 02/12/2004 | WO2004013275A2 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 02/12/2004 | WO2004013151A2 Campylobacter glycans and glycopeptides |
| 02/12/2004 | WO2004012837A2 Low pressure sperm cell separation system |
| 02/12/2004 | WO2004012791A2 Improved injection system |
| 02/12/2004 | WO2004012658A2 Method and device for protein delivery into cells |
| 02/12/2004 | WO2004012503A2 Compositions comprising muscle progenitor cells and uses thereof |
| 02/12/2004 | WO2003097812A3 Transgenic ungulates capable of human antibody production |
| 02/12/2004 | WO2003092474A3 Vascularization enhanced graft constructs |
| 02/12/2004 | WO2003091414A3 Adipocyte complement related protein zacrp8 |
| 02/12/2004 | WO2003080802A3 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 02/12/2004 | WO2003072697A3 Device and method for cultivating tissue cells |
| 02/12/2004 | WO2003072037A3 High-level production of amyloid-beta peptides from imr-32 cells |
| 02/12/2004 | WO2003072014A3 Minicell compositions and methods |
| 02/12/2004 | WO2003070171A9 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 02/12/2004 | WO2003068923A9 Signal for packaging of influenza virus vectors |
| 02/12/2004 | WO2003065994A3 Schwann cell and phosphodiesterase inhibitors based therapy |
| 02/12/2004 | WO2003064496A3 Biodegradable polymer |
| 02/12/2004 | WO2003064463B1 Pluripotency determining factors and uses thereof |
| 02/12/2004 | WO2003062467A3 Tissue rejection |
| 02/12/2004 | WO2003059264A3 Methods for the induction of professional and cytokine-producing regulatory cells |
| 02/12/2004 | WO2003056022B1 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 02/12/2004 | WO2003050262A3 Method for the generation of antigen-specific lymphocytes |
| 02/12/2004 | WO2003050250A3 Chondrocyte precursors derived from human embryonic stem cells |
| 02/12/2004 | WO2003050249A3 Islet cells from human embryonic stem cells |
| 02/12/2004 | WO2003046161A3 Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells |
| 02/12/2004 | WO2003045226A3 Eb matrix production from animal tissue and its use for tissue repair |
| 02/12/2004 | WO2003044203A3 Homologous recombination vector, preparations and uses |
| 02/12/2004 | WO2003039404A3 Methods for treating ocular neovascular diseases |
| 02/12/2004 | WO2003035012A3 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/12/2004 | WO2003033686A3 Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 02/12/2004 | WO2003033653B1 Affinity enhancement agents |
| 02/12/2004 | WO2003031589A8 Peptides and related compounds having thrombopoietic activity |
| 02/12/2004 | WO2003012041A3 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/12/2004 | WO2003010282A3 Interleukin-1 beta antibodies |
| 02/12/2004 | WO2003007805A3 Cartilage repair apparatus and method |
| 02/12/2004 | WO2002095051A3 Mage-a3 peptides presented by hla class ii molecules |
| 02/12/2004 | WO2002094196A3 Method of treatment for cancers associated with elevated |
| 02/12/2004 | WO2002081507A3 Interferon gamma polypeptide variants |
| 02/12/2004 | WO2002077895A3 Method for epigenetic feature selection |
| 02/12/2004 | WO2002077232A3 Compositions and methods relating to breast specific genes and proteins |
| 02/12/2004 | WO2002076507A3 Uses of opg ligand to modulate immune responses |
| 02/12/2004 | WO2002071927A3 Diagnosis and treatment of skeletal degeneration conditions |
| 02/12/2004 | WO2002069907A8 Anti-neovasculature preparations for cancer |
| 02/12/2004 | WO2002067863A3 Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002064747A3 Fusion proteins based upon somatostatin receptors |
| 02/12/2004 | WO2002064017A3 Immortalized human prostatic cancer cell lines |
| 02/12/2004 | WO2002062952A3 Non-cytotoxic pap mutants |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002046411A3 Intestinal proteins |
| 02/12/2004 | WO2001064926A8 Methods and compositions to reduce or eliminate transmission of a transgene |
| 02/12/2004 | US20040031075 Method of accumulating foreign gene product in plant seed at high level |
| 02/12/2004 | US20040031074 Isolated from tobacco, recombinant nucleic acids containing the same, expression vectors and transgenic plants produced therewith |
| 02/12/2004 | US20040031073 Method for modifying plant morphology, biochemistry and physiology |
| 02/12/2004 | US20040031067 Compositions and methods for preparing vascularized dermal reconstructs, vascularized skin grafts, and for enhancing vascularization in situ in response to a variety of medical conditions |
| 02/12/2004 | US20040030406 Tissue equivalent for transplantation and process for producing the same |
| 02/12/2004 | US20040030404 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 02/12/2004 | US20040030117 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents |
| 02/12/2004 | US20040030096 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | US20040029822 Detecting moderator of human chromosomes; calibration; genetic engineering; screening for nervous system defects in mammals |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029278 Recombinant alphaviruses which are capable of expressing a heterologous sequence in target cells |
| 02/12/2004 | US20040029277 Oligonucleotides specifically hybridizable with nucleic acids encoding Nitrogen Assimilation Control (NAC); for treating hyperproliferative disease, neurological disorders and aberrant apoptosis |
| 02/12/2004 | US20040029275 Short interfering RNA (siRNAs); reducing expression by obtaining and introducing into a cell multiple single or double stranded RNAs (dsRNAs) or DNA constructs capable of expressing multiple siRNAs in cells |
| 02/12/2004 | US20040029271 Pax5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy |
| 02/12/2004 | US20040029270 Vitro human angiogenesis model |
| 02/12/2004 | US20040029269 Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells |
| 02/12/2004 | US20040029268 Endothelialization of vascular surfaces |
| 02/12/2004 | US20040029265 A cell culture vessel used for culturing adherent cells in a high density and utilizing a substance produced by the cultured cells or cultured cells per se |
| 02/12/2004 | US20040029264 Advanced roller bottle system for cell and tissue culturing |
| 02/12/2004 | US20040029263 Disposable cell culture vessel |
| 02/12/2004 | US20040029251 Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/12/2004 | US20040029241 Formulation and use of a polymerization process employing biocompatible polymers and biocompatible polymerization conditions, such as neutral pH, where there is maintenance of an aqueous environment |
| 02/12/2004 | US20040029232 Novel G-protein coupled receptors |
| 02/12/2004 | US20040029229 High level protein expression system |
| 02/12/2004 | US20040029228 Cytokine receptor |
| 02/12/2004 | US20040029225 Lipoxygenase |
| 02/12/2004 | US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals |
| 02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/12/2004 | US20040029216 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections |
| 02/12/2004 | US20040029199 Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029187 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |
| 02/12/2004 | US20040029153 Method for estimating metabolic function of xenobiotic and induction thereof |